検索リコンビナントタンパク質
ACROBiosystems社 プロダクトリスト：Recombinant Protein
- サプライヤー
- AcroBioSystems
- カタログNo.
- HLV-H82E8
- 製品名称
- Biotinylated Human HLA-A*02:01&B2M&Vaccinia virus (IMYDIINSV) Complex Protein (Monomer, MALS verified)
- タンパク質名
- HLA-A*0201 & B2M & Vaccinia virus (IMYDIINSV)
- Species
- Human
- HOST
- HEK293
Overview
| Synonyms | - |
|---|---|
| Characteristics | Biotinylated Human HLA-A*02:01&B2M&Vaccinia virus (IMYDIINSV) Complex Protein is produced by co-expression of HLA and B2M loaded with Vaccinia virus peptide. This protein carries a polyhistidine tag at the C-terminus, followed by an Avi tag (Avitag?). The protein has a calculated MW of 36.3 kDa and 11.7 kDa. The protein migrates as 38-41 kDa and 10 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation. |
| Endotoxin Level | 1.0 EU per μg |
| Purity | 90% |
| Description | Among the nonvirion proteins of the vaccinia virus (VACV), a 94-kDa long protein is most abundantly present; the protein is a truncated form of the 150-kDa A-type inclusion (ATI) protein of the cowpox virus encoded by the ati gene. This VACV protein does not form intracellular ATIs, being as it is a major immunogen upon infection/immunization of humans or animals with the VACV. variants demonstrated that the mutant LIVPΔati elicits a stronger protective response compared to the parent LIVP. The human HLA-A*0201 Vaccinia virus IMYDIINSV complex protein is a complex of HLA-A*0201 of the MHC Class I, B2M, and IMYDIINSV peptide of the vaccinia virus. |
| Reference | - |
| URL | https://www.acrobiosystems.com/P7312-Biotinylated-Human-HLA-A%2A02%3A01B2MVaccinia-virus-%28IMYDIINSV%29-Complex-Protein-%28Monomer-MALS-verified%29.html |
お問い合わせリスト